Does Taking Semaglutide Helps Teens Lose Weight

Study show Taking Semaglutide Helping Teens Lose Weight Improve their Heart Health and other issues like type2 diabetes, and blood pressure.

Obesity in Teenagers is quite a common concern that has large consequences for their physical and mental health, reasons for teenage obesity also include genetic, unhealthy lifestyle eating habits with no physical activities, it also causes a variety of health issues like type 2 diabetes, heart problem and also higher blood pressure.

Does Taking Semaglutide Helping Teens Lose Weight and Improve Heart Health

Taking Semaglutide Really Helping Teens Weight loss and Improve Heart Health

Semaglutide is a medication that is used to help improve blood sugar control in adults with type 2 diabetes. It is not typically used to help with weight loss in teens.

It is important to note that weight loss medications should only be used under the guidance of a healthcare professional, and that lifestyle changes such as a healthy diet and regular physical activity are generally the most effective ways to achieve and maintain a healthy weight.

It is also important to address any underlying medical conditions that may be contributing to weight gain. Improving heart health typically involves making lifestyle changes.

such as eating a healthy diet, getting regular physical activity, and managing stress.

It is always important to talk to a healthcare professional about the best approach for improving your overall health.

Semaglutide is a kind of drug that is used to help control blood sugar pressure in teenagers with type 2 diabetes.

It does not typically use to help in weight loss. It is also important to know that weight loss supplements should only be used under the guidance of healthcare professionals.

The teenager should change their lifestyle a healthy diet and regular workouts are the affectivity ways to achieve and maintain healthy weight loss.

Semaglutide Weight Loss For Teens

 Recently a new study has been published in “The New England Journal of adolescents”

it was presented during Obesity week 2022 and has found that the medication “semaglutide” found effective in helping teens who are overweight or obese and looking off weight loss also improve their heart health.

During 3s clinical trials teenagers who consume semaglutide once a week, they experienced around a 16.1% reduction in their overall body mass index(BMI),

while another set of groups who take a placebo showed an increase of only 0.6% in their body mass index,

Semaglutide has already been approved for effective weight loss in teenagers.

Obesity is increasing rapidly not in just USA but around the world explained by Sr. author Silva Arslanian who is an M.D Professor of pediatric and clinical and translational science at Richard L.Day chair at the University of Pittsburg School of medicine.

The recommended lifestyle which is recommended by the health professionals like eating more vegetables, avoiding eating fried foods and excluding soft drinks like soda,

Somehow it seems that we are living in an unhealthy world and it is very difficult to make these changes.

So it was a need for safe and effective weight loss medications.

Semaglutide is considered to be a weight loss medication that imitates our internal hormones like glucagon peptide-1 and effect the specific part of the brain that controls appetite and control our eating.

In 2021 this medicine was approved for critical weight loss management in adults.

During this research around 201 people we enrolled between the age of 12 and 18 years were overweight and obese, these participants took Semaglutide 2.4 mg injection once a week or a placebo with strict lifestyle changes and counseling.

The Results after 68 weeks show that 72.5% of participants who took Semaglutide attained 5% of weight loss wherein only 17% of participants who consume a placebo,

Arslanian said that “Results are amazing” Arslanian is the director of pediatrics and clinical and Translational ResearchCenter and also the scientific director of the center for pediatric Research Facility in Obesity Pittsburg.

Every fifth child is affected by obesity or overweight around the world it increases serious health issues like type 2 diabetes, cardiovascular health, insomnia, and some types of cancers as well,

Teenagers with higher weight are likely to have depression, poor self-confidence, and self-esteem and also sometimes feel anxiety and other health issues.

The researchers displayed that participants who took Semaglutide shows a significant improvement in their cardiovascular risks including losing inches from their waistline, blood sugar matrix which is also known as HbA1c, low-density, and very low-density triglycerides cholesterol, lipoprotein, and liver enzymes in compression with the participants who took the placebo.

It was also observed that participants who took “Semaglutide” have better results in weight-related measures. Which is due to a boost in their physical comfort scores in compression with the placebo participants.

It was also claimed that this Semaglutide weight management medication is linked with lifestyle improvements in adults as well.

Reference: “Once-Weekly Semaglutide in teenagers with Obesity” by Daniel Weghuber, M.D., Timothy Barrett, Ph.D., Margarita Barrientos-Pérez, M.D., Inge Gies, Ph.D., Dan Hesse, Ph.D., Ole K. Jeppesen, M.Sc., Aaron S. Kelly, Ph.D., Lucy D. Mastrandrea, M.D., Rasmus Sørrig, Ph.D. and Silva Arslanian, M.D. for the STEP TEENS Investigators, 15 December 2022, New England Journal of Medicine.
DOI: 10.1056/NEJMoa2208601

This entire research was financially funded by Novo Nordisk A/S, the manufacturer of the semaglutide from the brand Wegov